These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16114862)

  • 1. [Breast cancer screening in France].
    Philip T; Kasparian C; Fagnani F; Moatti JP; Meunier A
    Bull Acad Natl Med; 2005 Feb; 189(2):321-36; discussion 336-9. PubMed ID: 16114862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of cancer registries in the evaluation of breast cancer screening].
    Schaffer P; Renaud R; Gairard B; Guldenfels C
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S15-21. PubMed ID: 8935860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast cancer screening: ethical problems. The Strasbourg experiment. Deontological issues raised by breast cancer screening: quality assurance and accreditation of structures].
    Haehnel P
    Bull Acad Natl Med; 1998; 182(8):1635-45; discussion 1646. PubMed ID: 10188309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer screening--the European experience.
    Perry NM
    Int J Fertil Womens Med; 2004; 49(5):228-30. PubMed ID: 15633481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stat bite: Frequency of breast cancer screening by health plan, 2000-2003.
    J Natl Cancer Inst; 2004 Nov; 96(22):1657. PubMed ID: 15547177
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts.
    Zapka JG; Puleo E; Taplin S; Solberg LI; Mouchawar J; Somkin C; Geiger AM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):46-54. PubMed ID: 16287885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organized breast cancer screening: experience at Bouches-du-Rhône].
    Seradour B
    Bull Acad Natl Med; 1998; 182(8):1665-7. PubMed ID: 10188312
    [No Abstract]   [Full Text] [Related]  

  • 8. [Breast cancer, the most frequent and the deadliest of all cancers in women].
    Roussanne C
    Rev Infirm; 2004 Jun; (102):20-7. PubMed ID: 15984730
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer screening for women aged 40 to 49 years--what does the evidence mean for New Zealand?
    Baker S; Wall M; Bloomfield A
    N Z Med J; 2005 Aug; 118(1221):U1628. PubMed ID: 16138166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
    Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
    J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality assurance in a mass screening project of breast cancer].
    den Otter G
    Ned Tijdschr Geneeskd; 1989 Mar; 133(10):502-3. PubMed ID: 2710230
    [No Abstract]   [Full Text] [Related]  

  • 12. [Should the general population be screened for breast cancer?].
    Schaffer P
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(8):750-4. PubMed ID: 9509314
    [No Abstract]   [Full Text] [Related]  

  • 13. [Speaking of breast cancer].
    Goddet B
    Soins Gynecol Obstet Pueric Pediatr; 1992; (135-136):3. PubMed ID: 1480995
    [No Abstract]   [Full Text] [Related]  

  • 14. [Breast cancer in Loire-Atlantique : situation before the mass screening campaign].
    Chouillet AM; Fiche M; Weber J
    Rev Epidemiol Sante Publique; 1999 Jun; 47(3):297-8. PubMed ID: 10422123
    [No Abstract]   [Full Text] [Related]  

  • 15. [Breast disease epidemiology. Screening for breast cancer].
    Lamarque JL; Pujol H; Dubois JB; Salicru B; Pujol J; Laurent JC; Regal R; Rodière MJ; Cherif-Cheik J; Rifaï A
    Soins Gynecol Obstet Pueric Pediatr; 1990 May; (108):31-7. PubMed ID: 2377956
    [No Abstract]   [Full Text] [Related]  

  • 16. [Breast cancer screening different from that used for the general population: who is concerned and with which approach?].
    Chappuis PO
    Rev Med Suisse; 2006 May; 2(66):1296-8, 1301-2, 1304-5. PubMed ID: 16775990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for breast cancer in Iran: a challenge for health policy makers.
    Mousavi SM; Harirchi I; Ebrahimi M; Mohagheghi MA; Montazeri A; Jarrahi AM; Gouya MM; Miller AB
    Breast J; 2008; 14(6):605-6. PubMed ID: 19000044
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of cancer screening programs in relation to screening recommendations].
    Saito H
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):871-6. PubMed ID: 15222103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
    Anderson BO; Shyyan R; Eniu A; Smith RA; Yip CH; Bese NS; Chow LW; Masood S; Ramsey SD; Carlson RW
    Breast J; 2006; 12 Suppl 1():S3-15. PubMed ID: 16430397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.